2.000 Å
X-ray
2004-11-02
Name: | Pol protein |
---|---|
ID: | Q8Q3H0_9HIV1 |
AC: | Q8Q3H0 |
Organism: | Human immunodeficiency virus 1 |
Reign: | Viruses |
TaxID: | 11676 |
EC Number: | / |
Chain Name: | Percentage of Residues within binding site |
---|---|
A | 49 % |
B | 51 % |
B-Factor: | 18.474 |
---|---|
Number of residues: | 45 |
Including | |
Standard Amino Acids: | 43 |
Non Standard Amino Acids: | 0 |
Water Molecules: | 2 |
Cofactors: | |
Metals: |
Ligandability | Volume (Å3) |
---|---|
0.959 | 830.250 |
% Hydrophobic | % Polar |
---|---|
45.53 | 54.47 |
According to VolSite |
HET Code: | 568 |
---|---|
Formula: | C34H40N2O9 |
Molecular weight: | 620.689 g/mol |
DrugBank ID: | DB01887 |
Buried Surface Area: | 67.97 % |
Polar Surface area: | 166.8 Å2 |
Number of | |
---|---|
H-Bond Acceptors: | 9 |
H-Bond Donors: | 6 |
Rings: | 5 |
Aromatic rings: | 3 |
Anionic atoms: | 0 |
Cationic atoms: | 0 |
Rule of Five Violation: | 3 |
Rotatable Bonds: | 14 |
X | Y | Z |
---|---|---|
13.4732 | 22.7899 | 5.37696 |
Represent the protein/ligand binding mode, centered on the ligand
Dashed lines represents hydrogen bonds and metal interactions
Green residue labels for amino acids with hydrophobic contacts (green lines) to the ligand
Ligand | Protein | Interaction | |||
---|---|---|---|---|---|
Atom | Atom | Residue | Distance (Å) | Angle (°) | Type |
C19 | CD2 | LEU- 23 | 3.7 | 0 | Hydrophobic |
C41 | CD2 | LEU- 23 | 3.68 | 0 | Hydrophobic |
O21 | OD2 | ASP- 25 | 2.71 | 169.68 | H-Bond (Ligand Donor) |
O23 | OD2 | ASP- 25 | 2.78 | 147.32 | H-Bond (Ligand Donor) |
N8 | O | GLY- 27 | 2.97 | 164.51 | H-Bond (Ligand Donor) |
N26 | O | GLY- 27 | 3.17 | 164.92 | H-Bond (Ligand Donor) |
C4 | CB | ALA- 28 | 4.37 | 0 | Hydrophobic |
C6 | CB | ALA- 28 | 3.91 | 0 | Hydrophobic |
C33 | CB | ALA- 28 | 3.65 | 0 | Hydrophobic |
O1 | N | ASP- 29 | 3.12 | 151.31 | H-Bond (Protein Donor) |
O36 | N | ASP- 29 | 3.2 | 145.69 | H-Bond (Protein Donor) |
C2 | CB | ASP- 29 | 4.26 | 0 | Hydrophobic |
C29 | CB | ASP- 29 | 4.1 | 0 | Hydrophobic |
O36 | OD2 | ASP- 29 | 2.91 | 146.53 | H-Bond (Ligand Donor) |
O7 | N | ASP- 30 | 2.82 | 140.85 | H-Bond (Protein Donor) |
C34 | CB | ASP- 30 | 3.63 | 0 | Hydrophobic |
C34 | CG2 | VAL- 32 | 3.44 | 0 | Hydrophobic |
C5 | CB | ILE- 47 | 4.48 | 0 | Hydrophobic |
C6 | CD1 | ILE- 47 | 4.46 | 0 | Hydrophobic |
C30 | CB | ILE- 47 | 4.32 | 0 | Hydrophobic |
C35 | CG2 | ILE- 47 | 3.94 | 0 | Hydrophobic |
C34 | CD1 | ILE- 47 | 4.04 | 0 | Hydrophobic |
C22 | CD1 | ILE- 50 | 4.19 | 0 | Hydrophobic |
C15 | CD1 | ILE- 50 | 3.95 | 0 | Hydrophobic |
C34 | CD1 | LEU- 76 | 4.41 | 0 | Hydrophobic |
C16 | CB | PRO- 81 | 3.64 | 0 | Hydrophobic |
C44 | CG | PRO- 81 | 3.54 | 0 | Hydrophobic |
C19 | CG2 | VAL- 82 | 3.75 | 0 | Hydrophobic |
C40 | CG1 | VAL- 82 | 3.66 | 0 | Hydrophobic |
C13 | CD1 | ILE- 84 | 3.47 | 0 | Hydrophobic |
C39 | CD1 | ILE- 84 | 3.54 | 0 | Hydrophobic |
O36 | O | HOH- 2007 | 3.21 | 129.79 | H-Bond (Protein Donor) |